Sclerostin Antibody Therapy for the Treatment of Osteoporosis: Clinical Prospects and Challenges

por MacNabb, Claire, Patton, D., Hayes, J. S.
Publicado 2016

Fine structural localization of potassium-stimulated rho nitrophenylphosphatase activity in denrites of the cerebral cortex

por Broderson, S. H., Patton, D. L., Stahl, W. L.
Publicado 1978

Inadvertent complication of the Senning procedure

por Moustafa, S., Merchant, N., Connelly, M. S., Patton, D. J.
Publicado 2016

Development of a complex community pharmacy intervention package using theory-based behaviour change techniques to improve older adults’ medication adherence

por Patton, D. E., Ryan, C., Hughes, C. M.
Publicado 2020

A community virtual ward model to support older persons with complex health care and social care needs

por Lewis, C, Moore, Z, Doyle, F, Martin, A, Patton, D, Nugent, LE
Publicado 2017

A pilot study of the S-MAP (Solutions for Medications Adherence Problems) intervention for older adults prescribed polypharmacy in primary care: study protocol

por Patton, D. E., Francis, J. J., Clark, E., Smith, F., Cadogan, C. A., Ryan, C., Hughes, C. M.
Publicado 2019

A non-randomised pilot study of the Solutions for Medication Adherence Problems (S-MAP) intervention in community pharmacies to support older adults adhere to multiple medications

por Patton, D. E., Pearce, C. J., Cartwright, M., Smith, F., Cadogan, C. A., Ryan, C., Clark, E., Francis, J. J., Hughes, C. M.
Publicado 2021

Recommendations on pregnancy, childbirth and aftercare in epidermolysis bullosa: a consensus‐based guideline

por Greenblatt, D.T., Pillay, E., Snelson, K., Saad, R., Torres Pradilla, M., Widhiati, S., Diem, A., Knight, C., Thompson, K., Azzopardi, N., Werkentoft, M., Moore, Z., Patton, D., Mayre‐Chilton, K.M., Murrell, D.F., Mellerio, J.E.
Publicado 2021

Corrigendum to ‘Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from...

por Jhaveri, K.L., Wang, X.V., Makker, V., Luoh, S.-W., Mitchell, E.P., Zwiebel, J.A., Sharon, E., Gray, R.J., Li, S., McShane, L.M., Rubinstein, L.V., Patton, D., Williams, P.M., Hamilton, S.R., Conley, B.A., Arteaga, C.L., Harris, L.N., O’Dwyer, P.J., Chen, A.P., Flaherty, K.T.
Publicado 2021

Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial

por Mansfield, A. S., Wei, Z., Mehra, R., Shaw, A. T., Lieu, C. H., Forde, P. M., Drilon, A. E., Mitchell, E. P., Wright, J. J., Takebe, N., Sharon, E., Hovelson, D., Tomlins, S., Zeng, J., Poorman, K., Malik, N., Gray, R. J., Li, S., McShane, L. M., Rubinstein, L. V., Patton, D., Williams, P. M., Hamilton, S. R., Conley, B. A., Arteaga, C. L., Harris, L. N., O’Dwyer, P. J., Chen, A. P., Flaherty, K. T.
Publicado 2022